C5aR1 antagonism suppresses inflammatory glial gene expression and alters cellular signaling in an aggressive Alzheimer's model.
Nicole D SchartzHeidi Yahan LiangKlebea CarvalhoShu-Hui ChuAdrian Mendoza-ArvillaTiffany J PetriskoAngela Gomez-ArboledasAli MortazaviAndrea J TennerPublished in: bioRxiv : the preprint server for biology (2023)
Pharmacologic inhibition of C5aR1 suppresses disease-enhancing processes and promotes disease mitigating pathways in an aggressive model of Alzheimer's disease.